What is the share price of RPG Life Sciences Ltd (RPGLIFE) today?
The share price of RPGLIFE as on 20th May 2026 is ₹2300. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on RPG Life Sciences Ltd (RPGLIFE) share?
The past returns of RPG Life Sciences Ltd (RPGLIFE) share are- Past 1 week: -0.43%
- Past 1 month: 13.87%
- Past 3 months: 20.82%
- Past 6 months: 3.37%
- Past 1 year: 7.28%
- Past 3 years: 197.23%
- Past 5 years: 401.36%
What are the peers or stocks similar to RPG Life Sciences Ltd (RPGLIFE)?
The peers or stocks similar to RPG Life Sciences Ltd (RPGLIFE) include:What is the dividend yield % of RPG Life Sciences Ltd (RPGLIFE) share?
The current dividend yield of RPG Life Sciences Ltd (RPGLIFE) is 1.04.What is the market cap of RPG Life Sciences Ltd (RPGLIFE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of RPG Life Sciences Ltd (RPGLIFE) is ₹3803.97 Cr as of 20th May 2026.What is the 52 week high and low of RPG Life Sciences Ltd (RPGLIFE) share?
The 52-week high of RPG Life Sciences Ltd (RPGLIFE) is ₹2725 and the 52-week low is ₹1733.What is the PE and PB ratio of RPG Life Sciences Ltd (RPGLIFE) stock?
The P/E (price-to-earnings) ratio of RPG Life Sciences Ltd (RPGLIFE) is 33.03. The P/B (price-to-book) ratio is 7.17.Which sector does RPG Life Sciences Ltd (RPGLIFE) belong to?
RPG Life Sciences Ltd (RPGLIFE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy RPG Life Sciences Ltd (RPGLIFE) shares?
You can directly buy RPG Life Sciences Ltd (RPGLIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
RPG Life Sciences Ltd
RPGLIFE Share Price
NSE₹2,300.000.76% (+17.40)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
RPGLIFE Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
RPGLIFE Performance & Key Metrics
RPGLIFE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 33.03 | 7.17 | 1.04% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 43.62 | 6.35 | 0.48% |
RPGLIFE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
RPGLIFE Company Profile
RPG Life Sciences Limited is engaged in manufacturing and marketing of pharmaceutical products. The Company operates across segments, including Domestic Formulations, International Formulations, Active Pharmaceutical Ingredients (API) and Biotech.
SUNPHARMA
PE Ratio
41.28
41.28
1Y Return
10.10%
10.10%
Buy Reco %
96.67
96.67
TORNTPHARM
PE Ratio
78.43
78.43
1Y Return
36.64%
36.64%
Buy Reco %
80.77
80.77
CIPLA
PE Ratio
29.14
29.14
1Y Return
3.77%
3.77%
Buy Reco %
62.86
62.86
DRREDDY
PE Ratio
26.23
26.23
1Y Return
7.98%
7.98%
Buy Reco %
51.52
51.52
MANKIND
PE Ratio
55.77
55.77
1Y Return
1.36%
1.36%
Buy Reco %
88.24
88.24
RPGLIFE Forecast
RPGLIFE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
RPGLIFE
RPGLIFE
Income
Balance Sheet
Cash Flow
Quarterly Normal View
RPGLIFE Income Statement
RPGLIFE Income Statement
Quarterly Normal View
| Quarter | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 176.02 | 258.05 | 165.73 | 197.44 | 183.44 | 190.39 | ||||||
Operating & Other expenses | 123.55 | 117.60 | 125.03 | 142.65 | 148.69 | 144.06 | ||||||
EBITDA | 52.47 | 140.45 | 40.70 | 54.79 | 34.75 | 46.33 | ||||||
| Depreciation/Amortization | 5.46 | 5.37 | 5.14 | 5.22 | 5.38 | 5.74 | ||||||
| PBIT | 47.01 | 135.08 | 35.56 | 49.57 | 29.37 | 40.59 | ||||||
| Interest & Other Items | 0.12 | 0.18 | 0.13 | 0.12 | 0.25 | 0.39 | ||||||
| PBT | 46.89 | 134.90 | 35.43 | 49.45 | 29.12 | 40.20 | ||||||
| Taxes & Other Items | 11.96 | 17.55 | 9.14 | 12.60 | 6.99 | 10.30 | ||||||
| Net Income | 34.93 | 117.35 | 26.29 | 36.85 | 22.13 | 29.90 | ||||||
| EPS | 21.12 | 70.96 | 15.90 | 22.28 | 13.38 | 18.08 |
RPGLIFE Company Updates
FY 2026FY 2026
Investor Presentation
Apr 30PDF
Oct 17PDF
Jul 25PDF
RPGLIFE Stock Peers
RPGLIFE Past Performance & Peer Comparison
RPGLIFE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| RPG Life Sciences Ltd | 33.03 | 7.17 | 1.04% |
| Sun Pharmaceutical Industries Ltd | 41.28 | 6.22 | 0.85% |
| Torrent Pharmaceuticals Ltd | 78.43 | 19.75 | 0.72% |
| Cipla Ltd | 29.14 | 3.61 | 0.93% |
RPGLIFE Stock Price Comparison
Compare RPGLIFE with any stock or ETFCompare RPGLIFE with any stock or ETF
RPGLIFE
RPGLIFE Holdings
RPGLIFE Shareholdings
RPGLIFE Promoter Holdings Trend
RPGLIFE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
RPGLIFE Institutional Holdings Trend
RPGLIFE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
RPGLIFE Shareholding Pattern
RPGLIFE Shareholding Pattern
RPGLIFE Shareholding History
RPGLIFE Shareholding History
Foreign Institutions
Mutual Funds Invested in RPGLIFE
Mutual Funds Invested in RPGLIFE
No mutual funds holding trends are available
Top 3 Mutual Funds holding RPG Life Sciences Ltd
| Funds (Top 3) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0399% | Percentage of the fund’s portfolio invested in the stock 0.80% | Change in the portfolio weight of the stock over the last 3 months 0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 49/65 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0003% | Percentage of the fund’s portfolio invested in the stock 0.07% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 89/130 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 764/1008 (+88) |
Compare 3-month MF holding change on Screener
smallcases containing RPGLIFE stock
smallcases containing RPGLIFE stock
Looks like this stock is not in any smallcase yet.
RPGLIFE Events
RPGLIFE Events
RPGLIFE Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
RPGLIFE has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.05%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹10.51 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
RPGLIFE Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
RPGLIFE has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.05%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹10.51 every year
RPGLIFE Upcoming Dividends
RPGLIFE Upcoming Dividends
No upcoming dividends are available
RPGLIFE Past Dividends
RPGLIFE Past Dividends
Cash Dividend
Ex DateEx DateJun 27, 2025
Final
Final | Div/Share: ₹20.00
Dividend/Share
₹20.00
Ex DateEx Date
Jun 27, 2025
Cash Dividend
Ex DateEx DateJun 27, 2025
Special
Special | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Jun 27, 2025
Cash Dividend
Ex DateEx DateJun 28, 2024
Final
Final | Div/Share: ₹16.00
Dividend/Share
₹16.00
Ex DateEx Date
Jun 28, 2024
Cash Dividend
Ex DateEx DateJul 21, 2023
Final
Final | Div/Share: ₹12.00
Dividend/Share
₹12.00
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 14, 2022
Final
Final | Div/Share: ₹9.60
Dividend/Share
₹9.60
Ex DateEx Date
Jul 14, 2022
RPGLIFE Stock News & Opinions
RPGLIFE Stock News & Opinions
Articles & Videos
Spotlight
RPG Life Sciences posts PAT of Rs 29.9 crore in Q4 FY26
The profit appears lower due to the exceptional gain that was recorded in Q4 FY25. Total operating expenses for Q4 FY26 added up to Rs 144.06 crore, up 22.5% YoY. Profit before tax in Q4 FY26 stood at Rs 40.20 crore, down by 70.2% from Rs 134.90 crore in Q4 FY25. For FY26, the company posted net profit and revenue of Rs 115.17 crore (down 37.1% YoY) and Rs 707.52 crore (up 8.3% YoY), respectively. The company said that in Q4, the Domestic Formulations (DF) business again delivered market-beating growth of 18.2%, compared to the Indian Pharma Market (IPM), which grew by 10.1% in the same period; a 1.8 times growth placing us significantly ahead of the market. The API division demonstrated strong comeback and registered a growth of 144.3% in Q4 on the back of unit coming back to operations. The growth surge especially stands out considering the fire in our API manufacturing plant in January 2025 and the timely restoration of our facility. Ashok Nair, managing director, RPG Life Sciences, said: 'Overall, we have built solid momentum with healthy growth in Q4 and for the full fiscal year, driven by sharper field effectiveness, operational discipline and an unwavering focus on our key brands. Looking ahead, we intend to strengthen our new product pipeline, sharpen equity of our existing brands, and drive field force effectiveness.' The board of directors at its meeting held today has recommended a final dividend of Rs 24 per equity share for FY25-26. RPG Life Sciences is an integrated research-based pharmaceutical company operating in the domestic and international markets in the branded formulations, global generics and synthetic APIs space. The scrip jumped 10.85% to currently trade at Rs 2242 on the BSE. Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Board of RPG Life Sciences recommends final dividend
RPG Life Sciences announced that the Board of Directors of the Company at its meeting held on 29 April 2026, inter alia, have recommended the final dividend of Rs 24 per equity Share (i.e. 300%) , subject to the approval of the shareholders.
2 weeks agoCapital Market - Live
Earnings
RPG Life Sciences consolidated net profit declines 74.52% in the March 2026 quarter
Net profit of RPG Life Sciences declined 74.52% to Rs 29.90 crore in the quarter ended March 2026 as against Rs 117.35 crore during the previous quarter ended March 2025. Sales rose 23.62% to Rs 176.89 crore in the quarter ended March 2026 as against Rs 143.09 crore during the previous quarter ended March 2025. For the full year,net profit declined 37.15% to Rs 115.17 crore in the year ended March 2026 as against Rs 183.24 crore during the previous year ended March 2025. Sales rose 8.28% to Rs 707.52 crore in the year ended March 2026 as against Rs 653.43 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales176.89143.09 24 707.52653.43 8 OPM %18.5617.81 -20.7924.43 - PBDT44.8430.37 48 171.78171.71 0 PBT39.1025.00 56 150.30150.28 0 NP29.90117.35 -75 115.17183.24 -37 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
RPG Life Sciences standalone net profit declines 36.64% in the December 2025 quarter
Net profit of RPG Life Sciences declined 36.64% to Rs 22.13 crore in the quarter ended December 2025 as against Rs 34.93 crore during the previous quarter ended December 2024. Sales rose 4.24% to Rs 180.03 crore in the quarter ended December 2025 as against Rs 172.71 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales180.03172.71 4 OPM %22.0928.46 - PBDT42.9252.35 -18 PBT37.5446.89 -20 NP22.1334.93 -37 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
RPG Life Sciences announces board meeting date
RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 27 January 2026.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
RPG Life Sciences standalone net profit rises 777.38% in the September 2025 quarter
Net profit of RPG Life Sciences rose 777.38% to Rs 36.85 crore in the quarter ended September 2025 as against Rs 4.20 crore during the previous quarter ended September 2024. Sales rose 5.50% to Rs 181.68 crore in the quarter ended September 2025 as against Rs 172.21 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales181.68172.21 5 OPM %21.4826.67 - PBDT43.4547.70 -9 PBT38.2342.39 -10 NP36.854.20 777 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
RPG Life Sciences schedules board meeting
RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 17 October 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
RPG Life Sciences standalone net profit declines 1.76% in the June 2025 quarter
Net profit of RPG Life Sciences declined 1.76% to Rs 26.29 crore in the quarter ended June 2025 as against Rs 26.76 crore during the previous quarter ended June 2024. Sales rose 2.12% to Rs 168.92 crore in the quarter ended June 2025 as against Rs 165.42 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales168.92165.42 2 OPM %21.0023.62 - PBDT40.5741.29 -2 PBT35.4336.00 -2 NP26.2926.76 -2 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
RPG Life Sciences to conduct board meeting
RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 25 July 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
RPG Life Sciences schedules AGM
RPG Life Sciences announced that the 18th Annual General Meeting(AGM) of the company will be held on 16 July 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 15.25%, vs industry avg of 9.86%
Over the last 5 years, market share increased from 0.15% to 0.18%
Over the last 5 years, net income has grown at a yearly rate of 44.58%, vs industry avg of 19.69%